Therefore, we suspect that direct targeting binding of S100A4 to the β-catenin/TCF complex in CRS regulates the Wnt/β-catenin signaling pathway, resulting in abnormal expression of the downstream EMT-related protein COL1A1, ultimately leading to tissue remodeling in the nasal mucosa. This evidence concerns the gene COL1A1 and congenital rubella syndrome.